Tag: matinas biopharma
October 18, 2018
Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001
Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,058,521... July 9, 2018